期刊文献+

大肠癌组织中端粒酶活性P53及nm23的表达和临床意义的研究

Expression and clinical significance of telomerase activity,P53 and nm23 in colorectal carcinoma
下载PDF
导出
摘要 目的探讨端粒酶活性、P53及nm23在原发性大肠癌组织中的表达和临床意义。方法应用免疫组织化学技术检测100例大肠癌P53和nm23的表达,同时应用原位杂交技术检测其中30例大肠癌及其癌旁组织、正常黏膜中端粒酶活性的表达,分析其与大肠癌的临床病理之间的关系。结果大肠癌组织中端粒酶阳性表达明显高于癌旁组织、正常黏膜组织(P<0.05),端粒酶表达强度与肿瘤的浸润深度、临床分期及淋巴结转移具有相关性(P<0.05)。P53阳性表达及强度与肿瘤的分化程度、临床分期显著相关(P<0.05)。P53表达与nm23低表达之间呈负相关(r=-0.115,P<0.05)。结论端粒酶的激活、p53基因突变及nm23基因缺失在大肠癌的发生发展中有一定的作用,联合检测端粒酶活性、P53、nm23对大肠癌的诊断、治疗及预后判断有意义,尤其P53与nm23同时检测更有价值。 Objective To evaluate expression and clinical significance of telomerase activity,P53 and nm23 in primary colorectal carcinoma.Methods The expression of P53 and nm23 were examined by immunohistochemical technique in 100 cases of colorectal carcinoma.Telomerase activity was examined by using in situ hybridization mRNA of telomerase.The relationship between the expression and clinical-pathological behaviors were analyzed.Results The positive expression of telomerase activity in cancer tissues was significantly higher than that in adjacent cancer tissues and in normal tissues(P〈0.05).Telomerase activity level in colorectal carcinoma was significantly associated with the invasion,clinicopathologic stage and lymph node metastasis(P〈0.05).The expression of P53 had a relevancy with the grade and clinical stage(P〈0.05).A minor relationship was observed between P53 over-expression and nm23 low-expression(r=-0.115).Conclusion The expression and level of telomerase activity,P53 gene and nm23 mutation play some roles in development of colorectal carcinoma.They might be a good sign and helpful in diagnosis,treatment and prognostic evaluation of colorectal carcinoma.The expression of P53 and nm23 examined simultaneously might be valuable.
出处 《山西医药杂志(上半月)》 CAS 2010年第12期1121-1123,共3页 Shanxi Medical Journal
关键词 肠肿瘤 端粒酶活性 P53蛋白 NM23 Intestinal neoplasms Telomerase activity P53 nm23
  • 相关文献

参考文献13

  • 1Hiyama E,Hiyama K.Clinical utlity of telomerase in cancer.Oncogene,2002,21(4):632-649.
  • 2Ikeguchi M,Makino M,Kaibara N.Telomerase activity and p53 gene mutation in familial polyposiscoli.Anticancer Res,2000,20(5c):3833-3837.
  • 3方向明,于皆平,余保平,沈志祥,罗和生.大肠癌组织端粒酶各组分基因表达及其与端粒酶活性的关系[J].临床内科杂志,2002,19(2):112-113. 被引量:3
  • 4陈海蔚,彭怀燕,陈道瑾.大肠癌端粒酶活性、p53蛋白表达的联合检测及其临床意义[J].中国现代医学杂志,2002,12(19):28-30. 被引量:8
  • 5Sanz-Casla MT,Vidaurreta M,Sanchez-Rueda D,et al.Telomerase activity as a prognostic factor in colorectal cancer.Onkologie,2005,28(11):553-557.
  • 6Hainaut P,Hollstein M.P53 and human cancer,the first ten thousand mutations.Adv Cancer Res,2000,77:81-137.
  • 7Ghavam-Nasiri MR,Rezaei E,Ghafarzadegan K,et al.Expression of P53 in colorectal carcinoma:correlation with clinicopathologic features.Arch Iran Med,2007,10(1):38-42.
  • 8Gallego MG,Acenero MJ,Ortega S,et al.Prognostic influence of P53 nuclear overexpression in colorectal carcinoma.Dis Colon Rectum,2000,43(7):971-975.
  • 9杨艳芳,王国栋,李佩珍,梁小波,丛娟.p53基因在大肠癌中的表达及预后意义[J].山西医药杂志,2002,31(3):184-185. 被引量:2
  • 10Sulkowska M,Famulski W,Guzinska-Ustymowicz K,et al.Study of P53 protein expression in colorectal cancer.Folia Histochem Cytobiol,2001,39(2):157-158.

二级参考文献7

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部